Biohale® sucrose
WebBioHale Sucrose is a non-reducing crystalline disaccharide made up of glucose and fructose. It is well suited to provide solution-state stabilization, as well as cryo and lyo … WebAug 25, 2024 · Goch, Germany (26 Aug 2024) – DFE Pharma, a global leader in pharmaceutical excipient solutions, is proud to announce its collaboration with AJM …
Biohale® sucrose
Did you know?
WebBioHale, the new range of excipient portfolio, consists of the highest purity excipients that can be used in the formulation. It contains BioHale Sucrose and BioHale Trehalose that is currently under development and will be … WebWith the launch of BioHale® Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in formulation. This new addition to the company’s well-established excipients’ portfolio aids …
WebBiohale® excipients are high-purity excipients that can be safely used for pulmonary and nasal delivery. Trehalose and sucrose are both listed in the USP-NF, PhEur and JPE. … WebFeb 7, 2024 · With the launch of BioHale Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in the formulation. The active participation of market players in product ...
WebFeb 28, 2024 · Company Contact: Jobe Dubbs, Vice President, Marketing, Spectrum Chemical, 310-359-9529, [email protected]. Source: Spectrum Chemical Mfg. Corp. Serious News for Serious Traders! Try ... WebSep 29, 2024 · Combining DFE Pharma’s BioHale portfolio of high purity excipients with the expertise in biologics by Spectrum Chemical makes for an ideal partnership that ensures a further distribution of these critical ingredients to market.” About DFE Pharma. DFE Pharma is a global leader in pharma- and nutraceutical excipient solutions.
WebAug 27, 2024 · DFE Pharma Proudly Supports COVID-19 Vaccination Supply in Pakistan BioHale® Sucrose, part of DFE Pharma’s BioHale® portfolio line, offers exceptional stabilization for biologics used in AJM Pharma vaccine while offering further security of supply. Goch, Germany (26 Aug 2024) – DF...
WebWe are excited to announce the global launch of our new product BioHale® Sucrose. Our BioHale® product line will support our customers to consistently provide industry leading solutions for ... fnf omega downloadWebAug 31, 2024 · DFE Pharma’s BioHale® Sucrose offers exceptional market purity and low endotoxin excipient in biologics formulation. Valued as excipient partner for over a century to many of the top global pharmaceutical brands, across various dosage forms from oral solid, respiratory, ophthalmic or parenteral application, DFE Pharma is uniquely positioned ... fnf on 911WebCryo- and Lyoprotectant. BioHale Sucrose, a high purity disaccharide excipient, protects the biologic drugs from the freeze related (cryoprotectant) and drying related … fnf omnipresent low endWebNext to BioHale Sucrose, our Trehalose further supports customers to choose what stabilizer works best in their individual biopharmaceutical formulation”, comments Bas van Driel, CEO of DFE Pharma. About DFE Pharma. DFE Pharma is a global leader in pharmaceutical excipient solutions. We strive to develop, produce and supply the highest ... greenview healthcareWebSucrose is an approved pharmaceutical excipient. It is listed in the USP-NF, Ph.Eur, BP, J.P, IP and Ch.P. Sucrose is part of the normal human and animal diet and approved for … fnf olleyWebBioHale® portfolio, comprised by BioHale® Sucrose and BioHale® Trehalose Dihydrate, can be used in various administration forms, such as for parenteral, inhalation, oral or … fnf oliver treeWebApr 21, 2024 · With the launch of BioHale® Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in formulation. This new addition to the company's well-established excipients' portfolio aids in stabilising biologics and offers drug developers and manufacturers worldwide the highest quality excipient technology and ... fnf omission